3CIBIS-Ⅱ Investigators and Committees.The Cardiac Insufficiency Bisoprolol StudyⅡ(CIBIS-Ⅱ):A randomized trial[J].Lancet,1999,353:2001-2006.
4Hjalmarson FG.Effects of controlled-release metoprolol on total mortality,hospitalization,and well-being in patients with hear failure,The Metoprolol CR/XLR and omized international Trial in Congestive Heart Failure(MERLT-HF)[J].JAMA,2000,283:295-302.
5Cesari M,Rossi GP,Pessina AC.Biological properties of the angiotensin peptides other than angiotentin Ⅱ:Implications for hypertension and cardiovascular diseases[J].J Hypertens,2002,20(5):799.
7Horiuchi M,Akishita M,Dzau VJ.Recent progress in angiotensin Ⅱtype receptor research in the cardiovascular system[J].Hypertension,1999,33(2):613-621.
8Levy BL.Can angiutensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease? Implication for therapeutic blockade of the renin-angiotentin system[J].Circulation,2004,109(1):8-13.
9Pfefer MA,Swedberg K,Granger CB,et al.CHARM Investigators and Comittees.Effects of candesartan onmortality and morbidity in patients with chronic heart failure:The CHARM -Overall programme.Cardesartan in heart failure:Assessment of readuction in morbidity and mortality(CHARM)[J].Lancet,2003,362:759-766.
10Pfeffer MC,Murray JJ,Velazquez EJ.Valsartan captopri lor both in myocardial infarction dysfunction,orboth.Valsartan in acute myocardial infarction trial(VALIANT)[J].N Engl J Med,2003,349:1893-1906.
2[1]Yamamoto K,Mano T,Yoshida L,et al.ACE inhibitor and angiotensin Il type Ⅰ receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failuer[J].J Hypertens,2005,23(2):393-400
3[2]Node K,fujita M,Kitakaze M,et al.Short torm statin therapy improves cardiac function and sympotms in patients with idiopathic dilated crdiomyopatthy[J].Circulation,2003,108(7):839-843
4[3]Horwich TB,Maclellan WR,Fonarow GC,et al.Statin therapy is associated with improved survival in ischemic and non ischernic heart failure[J].J Am Coll Cordiol,2004,43(4):624-648
5[4]Hognestad A,Dickstein K,Myhre E,et al.Effect of combined statin and beta-blocker treatment on one-year mrodidity and mortality after acute myocardial infarction associated with heart failure[J].Am J Cardiol,2004,93(5):603-606
6[5]Lubien E,Denaria A,Kazanegre R,et al.Utiliy of B-tye natriuretic in detecting diastolic dysfunction:comparison with Dopple welocity recordings[J].Circulation,2002,105(3):595-601
8[7]Harjai KJ,Nunez E,Turgut T,et al.Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus alone on readmisson rates in heart failure[J].Am J Cardiol,2002,88 (4):483-487
9[8]Krumholz HM,Chen YT,Radford MJ,et al.Aspirin and the treatment of heart failuer in the elderly[J].Arch Intern Med,2002,162 (4):577-582
10[11]Gheorghiade M,Gattis WA,Connor CM,et al.Effects of tolvaptan,a vasopressin antagonist,in patients hospitazed with worsting heart failure[J].JAMA,2004,291(16):1936-1971
7Poole PA,Swedberg K,Cleand JG,et al.Comparison of carvedilol and metoprolol on clinical cutcomes in patients with CHF in the carvediIol or metoprolol European trail(COMET):randomized controlled trial[J].Lancet,2003,357(2267):7-13.
8Peter J V,Moran J L,Phillips Hughes J,et al.Effect of non in-vasive positive pressure ventilation (NIPPV)on mortality inpatients with acute cardiogenic pulmonary edema:a meta-anal-ysis. The Lancet . 2006
9Rudan I,Boschi-Piuto C,Biloglav Z, et al.Epidemiology and etiology of childhood pneumonia. Bulletin of the World Health Organization . 2008
